ME00190B - Preparati za restruktuiranje nokta za topikalnu primjenu - Google Patents
Preparati za restruktuiranje nokta za topikalnu primjenuInfo
- Publication number
- ME00190B ME00190B MEP-2008-231A MEP2008231A ME00190B ME 00190 B ME00190 B ME 00190B ME P2008231 A MEP2008231 A ME P2008231A ME 00190 B ME00190 B ME 00190B
- Authority
- ME
- Montenegro
- Prior art keywords
- preparation according
- fact
- extract
- component
- preparation
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract 4
- 230000000699 topical effect Effects 0.000 title claims abstract 3
- 238000002360 preparation method Methods 0.000 claims abstract 29
- 239000003795 chemical substances by application Substances 0.000 claims abstract 9
- 244000085625 Equisetum Species 0.000 claims abstract 4
- 239000000284 extract Substances 0.000 claims 8
- 229920001661 Chitosan Polymers 0.000 claims 7
- 241000196324 Embryophyta Species 0.000 claims 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 4
- 239000012675 alcoholic extract Substances 0.000 claims 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims 2
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 125000004181 carboxyalkyl group Chemical group 0.000 claims 2
- 239000006184 cosolvent Substances 0.000 claims 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims 2
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims 2
- LKAPTZKZHMOIRE-KVTDHHQDSA-N (2s,3s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolane-2-carbaldehyde Chemical class OC[C@H]1O[C@H](C=O)[C@@H](O)[C@@H]1O LKAPTZKZHMOIRE-KVTDHHQDSA-N 0.000 claims 1
- 241000195950 Equisetum arvense Species 0.000 claims 1
- 239000005768 Equisetum arvense L. Substances 0.000 claims 1
- 241000195955 Equisetum hyemale Species 0.000 claims 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 claims 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims 1
- 241000208202 Linaceae Species 0.000 claims 1
- 235000004431 Linum usitatissimum Nutrition 0.000 claims 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 1
- 208000002474 Tinea Diseases 0.000 claims 1
- 241000893966 Trichophyton verrucosum Species 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- 125000003158 alcohol group Chemical group 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 230000000844 anti-bacterial effect Effects 0.000 claims 1
- 239000002260 anti-inflammatory agent Substances 0.000 claims 1
- 229940121363 anti-inflammatory agent Drugs 0.000 claims 1
- 239000004599 antimicrobial Substances 0.000 claims 1
- 239000003963 antioxidant agent Substances 0.000 claims 1
- 235000019568 aromas Nutrition 0.000 claims 1
- 210000003050 axon Anatomy 0.000 claims 1
- 230000003115 biocidal effect Effects 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims 1
- 239000002738 chelating agent Substances 0.000 claims 1
- 230000002708 enhancing effect Effects 0.000 claims 1
- 239000003906 humectant Substances 0.000 claims 1
- 229940054190 hydroxypropyl chitosan Drugs 0.000 claims 1
- 239000004611 light stabiliser Substances 0.000 claims 1
- 239000003589 local anesthetic agent Substances 0.000 claims 1
- 229940016409 methylsulfonylmethane Drugs 0.000 claims 1
- 230000035515 penetration Effects 0.000 claims 1
- 238000004062 sedimentation Methods 0.000 claims 1
- 150000004760 silicates Chemical class 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- HHVIBTZHLRERCL-UHFFFAOYSA-N sulfonyldimethane Chemical compound CS(C)(=O)=O HHVIBTZHLRERCL-UHFFFAOYSA-N 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- 239000011593 sulfur Substances 0.000 claims 1
- 229960003080 taurine Drugs 0.000 claims 1
- DZLNHFMRPBPULJ-UHFFFAOYSA-N thioproline Chemical compound OC(=O)C1CSCN1 DZLNHFMRPBPULJ-UHFFFAOYSA-N 0.000 claims 1
- 229950001139 timonacic Drugs 0.000 claims 1
- 239000012049 topical pharmaceutical composition Substances 0.000 claims 1
- 238000009472 formulation Methods 0.000 abstract 2
- 206010048886 Onychoclasis Diseases 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- 239000006071 cream Substances 0.000 abstract 1
- 230000003292 diminished effect Effects 0.000 abstract 1
- 239000006260 foam Substances 0.000 abstract 1
- 239000000499 gel Substances 0.000 abstract 1
- 239000004922 lacquer Substances 0.000 abstract 1
- 239000006210 lotion Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/736—Chitin; Chitosan; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9741—Pteridophyta [ferns]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q3/00—Manicure or pedicure preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q3/00—Manicure or pedicure preparations
- A61Q3/02—Nail coatings
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Birds (AREA)
- Microbiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Ovaj pronalazak je usmjeren na preparate koji sadrže kombinaciju biljke rodaEquisetum zajedno sa jednim sredstvom za stvaranje filma i njihovu primjenu kao topikalnihformulacija za nokte, kao što su lak, krem, gel, losion ili pjena. Ovaj pronalazak je daljeusmjeren ka primjeni sredstava za stvaranje filma koja su rastvorljiva u vodi kao aditiva utopikalnoj formulaciji za nokte. Ovi preparati mogu biti primijenjeni za liječenje specifičnihpromjena strukture nokta, kao što je smanjena jačina, onihošizija i krtost noktiju.
Claims (24)
1. Preparat, naznačen time, što sadrži : a) najmanje jedan ekstrakt biljke iz roda Equisetum, b) najmanje jedno sredstvo za stvaranje filma.
2.Preparat prema za htevu l , naznače n time, što dalje sad rži e) najmanje jedan fiziološki prihvatlji v n osač.
3. Preparat prema bilo kome od prethodnih zahteva, naznačen time što sadrži d) najmanje jedan donor s umpora.
4.Preparat prema bilo kome od prethodnih zahteva, naznačen time što je komponenta a) izabrana od : Equisetun arvense u obliku biljke ili dela biljke, soka, s uvog ekstrakta, alkoholnog ekstrakta, vodeno- alkoholnog ekstrakta ili gliko lnog ekstrakta, ili Equisetum hiemale obliku biljke ili dela biljke, soka, suvog ekstrakta, alkoholnog ekstrakta, vodeno -alkoholnog ekstrakta ili glikolnog ekstrakta.
5.Preparat prema bilo kome od prethodnih zahteva, naznačen time što je komponenta a) glikolni ekstrakt Equisetum arvense.
6.Preparat prema bilo kome od prethodnih zahteva, naznaćen time što je komponenta b) sred stvo za stvaranje filma koje je rastvo rljivo u vodi .
7.Preparat prema zahtevu 6, naznaćen time što je pomenuto sredstvo za stvaranje filma koje je rastvorljivo u vodi derivat hitozana.
8. Preparat prema zahtevu 7, naznačen time što je pomenuti derivat hitoza na izabran od hidroksialkil hitoza na i /ili karboksialkil hitozana.
9. Preparat prema zahtevu 8, naznačen time što je pomenuti hidroksialkil hitozan izabran od hitoza na koji s u derivatizovani sa C1 .6 a lkil gr upam a koje imaju l do 3 hidro ksi grupe, prioritetno hidroksipropil hitozan.
10.Preparat prema zahtevu 8, naznačen time što je pomenuti karboksialkil h itoza n izabran od hitozana koji su derivatizovani sa cl-6 alkil grupama koje imaju l do 3 hidroksi grupe, prioritetno karboksimetil hitozan.
11. Preparat prema bilo kome od prethodnih zahteva, naznačen time što je komponenta e) voda ili smeša vode sa najmanje jednim ko-rastvaračem.
12.Preparat prema zahtvu ll , naznačen time što je pom enuti ko-rastvarač alkohol.
13.Preparat prema zahtevu 12, naznačen time što je pomenuti alkohol, alkohol pravog ili razgranatog lanca, koji ima l do 3 hidroksi grupe i 2 do 6 ugljenikovih atoma, prioritetno etanol, 1-propanol i/ili izopropanol.
14.Preparat prema bilo kome od prethodnih zahteva, naznačen time što je komponenta d) izabrana od sulfatizovanih amino kiselina i njihovih derivata, l metionina, l-cisteina,, l-cistina, taurina, 4-tiazolidinkarboksilne kiseline i /ili metilsulfonilmetana.
15.Preparat prema bilo kome od prethodnih zahteva, naznačen time što sadrži i sredstva za pojačanje penetracije, sredstva za usporavanje sedimentacije, helataci o na sredstva, antioksidante, si likate, aromate, ovlaživače, derivate lan o lina, stabili zato re svetl ost i i /ili antibakterijske supstance.
16.Preparat prema bilo kome od prethodnih zahteva, naznačen time što sadrž i i dodatna aktivna sredstva izabrana od antimiotičkih sredstava, antibiotičkih sredstava, anti-inflamatornih sredstava, antiseptičkih sred stava i /ili l okalnih anestetečkih sred stava.
17.Preparat prema bilo kome od preth odnih zahteva, naz nače n time što je komponenta a) prisutna u količini od 0. 1 do 15 tež. %, prioritetn o 0. 3 do 1 5 tež. %, prioritetnije 0.5 do l O tež. %od težine ukupnog preparata.
18.Preparat prema bilo kome od prethodnih zahteva, naznačen time što je kompon enta b) prisutna u količini od 0.1 d o 10 tež. %, prioritetn o 0. 3 d o 8 tež. %, prioritetnije 0.5 d o 5 tež. %od težine ukupnog preparata.
19.Preparat prem a bilo kome od prethodnih zahteva, naznačen tim e što je kompone nta e) prisutna u količini od 40 do 99.8 tež. %, prioritetno 60 d o 99 tež. %, prioritetnije 80 d o 95 tež. %od težine ukupnog pre parata.
20.Pre parat prema zahtevu 1 9, naznačen tim e što je sadržaj vod e u komponen t i e) 1 5 d o 70 tež. %, pri oritetno 30 d o 65 tež. od tež ine kome ponente e).
21.Preparat prema bil o kome od prethodnih zahteva, naz načen tim e što je kompo nenta d) pris utna u količini od 0.1 d o 20 tež. %, pri oritetno 0.3 d o l O tež. % od tež ine ukupnog preparata.
22. Preparat prema bilo kome od prethodnih zahteva, naznačen tim e što se u su štini sastoj i od e) najmanje jednog ekstrakta biljke iz roda Equisetum, d) najmanje jednog sredstva za stvaranje film a, e) najmanje jednog fi zio l oški prih vatlji vog nosača, f) najmanje jedn og d onora sumpora
23.Primena pr e parata prema bil o kome od prethodnih zahteva kao to pi ka ln e fo rmulacije za n okat.
24.Prim e na najmanje jedn og ekstrakta biljke i z roda Equi se tum i n ajm a nje jedn og s red st va za stvaranje filma za d obijanje topi kalnog preparata za l eće nje o nihoš i z ije.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20030076934 EP1491202A1 (en) | 2003-06-23 | 2003-06-23 | Nail restructuring compositions for topical application |
| PCT/EP2004/006549 WO2004112814A1 (en) | 2003-06-23 | 2004-06-15 | Nail restructuring compositions for topical application |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ME00190B true ME00190B (me) | 2011-02-10 |
Family
ID=33395922
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MEP-231/08A MEP23108A (en) | 2003-06-23 | 2004-06-15 | Nail restructuring compositions for topical application |
| MEP-2008-231A ME00190B (me) | 2003-06-23 | 2004-06-15 | Preparati za restruktuiranje nokta za topikalnu primjenu |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MEP-231/08A MEP23108A (en) | 2003-06-23 | 2004-06-15 | Nail restructuring compositions for topical application |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US20060134039A1 (me) |
| EP (2) | EP1491202A1 (me) |
| JP (1) | JP5037121B2 (me) |
| KR (2) | KR20120027554A (me) |
| CN (1) | CN100430044C (me) |
| AT (1) | ATE369870T1 (me) |
| BR (1) | BRPI0411705B1 (me) |
| CA (1) | CA2528313C (me) |
| CY (1) | CY1106949T1 (me) |
| DE (1) | DE602004008272T2 (me) |
| DK (1) | DK1635852T3 (me) |
| ES (1) | ES2289527T3 (me) |
| HR (1) | HRP20070431T3 (me) |
| IL (1) | IL172180A (me) |
| ME (2) | MEP23108A (me) |
| MX (1) | MXPA05013820A (me) |
| PT (1) | PT1635852E (me) |
| RS (1) | RS51879B (me) |
| RU (1) | RU2358748C2 (me) |
| SI (1) | SI1635852T1 (me) |
| WO (1) | WO2004112814A1 (me) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060127342A1 (en) * | 2004-12-09 | 2006-06-15 | Georgia Levis | Taurine-based compositions, therapeutic methods, and assays |
| EP1958638A1 (en) * | 2007-02-14 | 2008-08-20 | Polichem S.A. | Use of chitosans to increase nail growth rate |
| EP1958639A1 (en) | 2007-02-14 | 2008-08-20 | Polichem S.A. | Use of chitosans for the treatment of nail inflammatory diseases |
| US10201490B2 (en) | 2007-02-14 | 2019-02-12 | Polichem Sa | Use of chitosans for the treatment of nail inflammatory diseases |
| EP1958613A1 (en) * | 2007-02-15 | 2008-08-20 | Polichem S.A. | Dermal film-forming liquid formulations for drug release to skin |
| IT1390844B1 (it) * | 2008-07-29 | 2011-10-19 | Trasdeco Int S R L | Composizione cosmetica per unghie e relativo metodo di applicazione |
| EP2153836A1 (en) * | 2008-08-04 | 2010-02-17 | Polichem S.A. | Film-forming liquid formulations for drug release to hair and scalp |
| EP2116237A1 (en) | 2008-08-05 | 2009-11-11 | Polichem SA | Compositions for treating rosacea comprising chitosan and a dicarboxylic acid |
| TR201103770A1 (tr) * | 2011-04-19 | 2012-11-21 | Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ | Nimesulid ve metilsülfonilmetanin topikalfarmasötik bileşimleri. |
| US8697753B1 (en) | 2013-02-07 | 2014-04-15 | Polichem Sa | Method of treating onychomycosis |
| EP2845597A1 (en) * | 2013-09-10 | 2015-03-11 | Polichem S.A. | Hydroxypropyl chitosan for the treatment of onychomycosis |
| EP2952208A1 (en) * | 2014-06-04 | 2015-12-09 | Universidade de Santiago de Compostela | Hydroalcoholic system for nail treatment |
| JP6570316B2 (ja) * | 2015-05-25 | 2019-09-04 | ロート製薬株式会社 | 爪用組成物 |
| KR102485403B1 (ko) | 2020-08-31 | 2023-01-17 | 주식회사 비앤에이치웍스 | 손발톱 강화용 조성물 |
| KR102597564B1 (ko) * | 2023-03-03 | 2023-11-03 | 장병모 | 조갑 및 피부 백선의 예방 또는 치료용 약학적 조성물 |
| EP4781195A1 (en) * | 2024-01-11 | 2026-07-29 | Bios-Therapy, Physiological Systems for Health S.p.A. | Methods for determining when a natural therapeutic or beneficial product exerts its therapeutic or beneficial effect through a physiological mode of action |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2610523B1 (fr) * | 1987-02-06 | 1991-04-26 | Synthelabo | Extrait dose de silicium biogene, sa preparation et son application en therapeutique |
| US5133958A (en) * | 1989-04-20 | 1992-07-28 | Erwin Stuckler | Agent for nail, skin and hair care |
| US5478579A (en) * | 1991-02-06 | 1995-12-26 | Biodyn Medical Research, Inc. | Method for treatment of osteoporosis |
| FR2681782B1 (fr) * | 1991-09-26 | 1993-12-17 | Oreal | Composition pour le traitement des ongles contenant un aminoacide soufre. |
| ATE171070T1 (de) * | 1993-05-02 | 1998-10-15 | Helmut Koeniger | Neue verwendung von equisetum |
| FR2718637A1 (fr) * | 1994-04-15 | 1995-10-20 | Oreal | Composition cosmétique à appliquer sur l'ongle. |
| RU2083224C1 (ru) | 1994-09-30 | 1997-07-10 | Сергей Федорович Подчайнов | Противогрибковое средство для стоп |
| US6027402A (en) * | 1996-11-18 | 2000-02-22 | Sunfiles, Llc | Cosmetic file/buffer with microencapsulated treatment substances |
| AU7174998A (en) * | 1997-05-01 | 1998-11-24 | Medlogic Global Corporation | Compositions for cosmetic applications |
| JPH11193217A (ja) * | 1997-12-26 | 1999-07-21 | Kao Corp | ネイルトリートメント組成物 |
| US6919076B1 (en) * | 1998-01-20 | 2005-07-19 | Pericor Science, Inc. | Conjugates of agents and transglutaminase substrate linking molecules |
| DE19826943C2 (de) | 1998-06-17 | 2001-12-06 | Daimler Chrysler Ag | Tunnelverkleidung für ein Kraftfahrzeug |
| WO2000003679A2 (en) | 1998-07-14 | 2000-01-27 | Adams Food Ltd. | Nutritionally active composition for hardening fingernails |
| US6589571B2 (en) * | 1998-08-13 | 2003-07-08 | Helmut Koniger | Method for combating summer eczema and malanders |
| RU2140264C1 (ru) * | 1998-09-24 | 1999-10-27 | Тихоокеанский институт биоорганической химии Дальневосточного отделения РАН | Средство для наружного применения "полимед" |
| KR20010026947A (ko) * | 1999-09-09 | 2001-04-06 | 이충삼 | 건강보조식품 제조방법 |
| US6596266B2 (en) * | 2000-02-18 | 2003-07-22 | Natural Science, Inc. | Compositions containing minoxidil and saw palmetto for treating baldness |
| DE10035991A1 (de) * | 2000-07-24 | 2002-02-14 | Polichem Sa | Nagellackzusammensetzung |
| RU2206315C2 (ru) * | 2000-08-17 | 2003-06-20 | Черных Сергей Львович | Лечебно-косметический крем |
| JP2002179521A (ja) * | 2000-12-13 | 2002-06-26 | Ichimaru Pharcos Co Ltd | 植物又は動物抽出物含有化粧料組成物 |
| EP1275371A1 (en) * | 2001-07-13 | 2003-01-15 | Johnson and Johnson GmbH | Dry products comprising a sheet and two phases |
| FR2829696B1 (fr) * | 2001-09-17 | 2004-02-27 | Oreal | Utilisation de l'acide pantetheine sulfonique et/ou de ses sels en tant qu'agent anti-radicalaire |
| US6844303B2 (en) * | 2001-12-14 | 2005-01-18 | Rainer Lange | Cleaning compositions and their use in feminine hygiene wipes |
| CA2383296A1 (fr) * | 2002-05-10 | 2003-11-10 | Ginette Godbout | Composition pour l'amelioration de la sante et de la structure des ongles, methode d'utilisation |
-
2003
- 2003-06-23 EP EP20030076934 patent/EP1491202A1/en not_active Withdrawn
-
2004
- 2004-06-15 BR BRPI0411705-0A patent/BRPI0411705B1/pt not_active IP Right Cessation
- 2004-06-15 SI SI200430460T patent/SI1635852T1/sl unknown
- 2004-06-15 ME MEP-231/08A patent/MEP23108A/xx unknown
- 2004-06-15 WO PCT/EP2004/006549 patent/WO2004112814A1/en not_active Ceased
- 2004-06-15 ES ES04740007T patent/ES2289527T3/es not_active Expired - Lifetime
- 2004-06-15 JP JP2006515978A patent/JP5037121B2/ja not_active Expired - Lifetime
- 2004-06-15 KR KR1020127005145A patent/KR20120027554A/ko not_active Ceased
- 2004-06-15 RU RU2006101686/15A patent/RU2358748C2/ru active
- 2004-06-15 CN CNB2004800177364A patent/CN100430044C/zh not_active Expired - Lifetime
- 2004-06-15 ME MEP-2008-231A patent/ME00190B/me unknown
- 2004-06-15 RS YU20050925A patent/RS51879B/sr unknown
- 2004-06-15 PT PT04740007T patent/PT1635852E/pt unknown
- 2004-06-15 CA CA2528313A patent/CA2528313C/en not_active Expired - Lifetime
- 2004-06-15 AT AT04740007T patent/ATE369870T1/de active
- 2004-06-15 MX MXPA05013820A patent/MXPA05013820A/es active IP Right Grant
- 2004-06-15 US US10/559,794 patent/US20060134039A1/en not_active Abandoned
- 2004-06-15 HR HR20070431T patent/HRP20070431T3/xx unknown
- 2004-06-15 KR KR1020057023566A patent/KR101140272B1/ko not_active Expired - Lifetime
- 2004-06-15 EP EP04740007A patent/EP1635852B1/en not_active Expired - Lifetime
- 2004-06-15 DE DE602004008272T patent/DE602004008272T2/de not_active Expired - Lifetime
- 2004-06-15 DK DK04740007T patent/DK1635852T3/da active
-
2005
- 2005-11-24 IL IL172180A patent/IL172180A/en active IP Right Grant
-
2007
- 2007-10-22 CY CY20071101358T patent/CY1106949T1/el unknown
-
2010
- 2010-02-26 US US12/659,140 patent/US8318214B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7320581B2 (ja) | ジフェンヒドラミン又はその塩並びにアスコルビン酸又はその塩を含有する外用組成物の変色抑制方法 | |
| KR970009800A (ko) | 경구 투여용 약제학적 조성물 | |
| PE20080374A1 (es) | Composiciones farmaceuticas de ropinirol | |
| US8318214B2 (en) | Method for treating onychoschizia | |
| BRPI0414883A (pt) | composição, concentrado de composição, e, composições alcoólicas desinfetante e semelhante a gel | |
| JP2007153910A (ja) | 抗真菌マニキュア組成物 | |
| DE102014116903A1 (de) | Cineolhaltige Zusammensetzung für die nasale Applikation | |
| HRP20130071T1 (hr) | Poboljšani testosteron u gelu i naäśin primjene | |
| UA102187C2 (ru) | Фармацевтическая композиция для пероральной доставки дииндолилметана | |
| RS54961B1 (sr) | Farmaceutska kompozicija za lečenje promuklosti ili bolova u grlu | |
| AR064263A1 (es) | Composiciones farmaceuticas que comprenden un compuesto bisfosfato | |
| BRPI0411702B8 (pt) | uso de ácido hialurônico para preparar composições para o tratamento de aftas da cavidade oral | |
| RU2018125252A (ru) | Синергическая комбинация пирролидонкарбоновой кислоты и/или ее солей и гиалуроновой кислоты и/или ее солей для применения в лечении и/или профилактике сухости и раздражения слизистых оболочек, и связанные фармацевтические композиции | |
| RS53034B (sr) | Topikalne farmaceutske kompozicije gela od flurbiprofena, glukozamina i hondroitina | |
| PE20050359A1 (es) | Composiciones topicas que comprenden terbinafina e hidrocortisona | |
| JP7271927B2 (ja) | 外用組成物 | |
| DE60005548D1 (de) | Zusammensetzung enthaltend einen extrakt aus perna canaliculus, methylsulfonylmethan und glucosamine und verwendung | |
| IT202000022042A1 (it) | Composizioni topiche antivirali comprendenti acido ialuronico e carragenina | |
| WO2024104313A1 (en) | Composition for antiviral or oxidation pretreatment, preparation method and usage method thereof | |
| BR102016016340A2 (pt) | Formulação mucosal antimicrobiana e uso de formulação mucosal antimicrobiana | |
| RU2705200C1 (ru) | Спрей для профилактики инфекционно-респираторных заболеваний | |
| ES2749128T3 (es) | Composición para el tratamiento de rinitis | |
| JP2025036378A (ja) | 口内炎発症抑制組成物 | |
| CO2021009028A2 (es) | Composiciones para uñas con propiedades antifúngicas | |
| JP2024006898A (ja) | 外用組成物 |